Developing and implementing oral 5-HT3 receptor antagonist guidelines: a multidisciplinary process.
Rough
S S
SS
Evanston Hospital 60201, USA.
Carro
G W
GW
D000284:Administration, Oral; D000932:Antiemetics / Q000008:administration & dosage* / Q000191:economics; D002173:Cancer Care Facilities; D005260:Female; D006745:Hospital Bed Capacity, 300 to 499; D006801:Humans; D007087:Illinois; D007262:Infusions, Intravenous; D008297:Male; D009325:Nausea / Q000139:chemically induced* / Q000517:prevention & control; D009369:Neoplasms / Q000150:complications / Q000188:drug therapy*; D016522:Oncology Service, Hospital; D017294:Ondansetron / Q000008:administration & dosage* / Q000191:economics; D010607:Pharmacy Service, Hospital / Q000191:economics / Q000592:standards*; D017410:Practice Guidelines as Topic; D012702:Serotonin Antagonists / Q000008:administration & dosage* / Q000191:economics
D000932:Antiemetics; D012702:Serotonin Antagonists; D017294:Ondansetron